Supernus Expands Partnership With MERGE as AI-Powered Agency of Record

GlobeNewswire··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Supernus Pharmaceuticals has expanded its partnership with MERGE, naming the agency its Agency of Record for the ADHD treatment QELBREE and its full digital ecosystem. The expanded agreement unifies Supernus' digital marketing and technology platforms, with MERGE leading omnichannel strategy and taking over website development and CRM operations. MERGE will continue to support Supernus' Parkinson's disease brands APOKYN, GOCOVRI, and ONAPGO, while using its Contextual Spectrum approach to deliver personalized digital experiences. The partnership builds on a seven-year relationship and will leverage MERGE's AI-first blueprint to enhance engagement across Supernus' CNS portfolio.

Impact on assets 2

Biotech & Genomic Medicine▲
Supernus Pharmaceuticals Inc
SUPN
▲ PositiveDemandrelevance

Expanded partnership with MERGE as Agency of Record for QELBREE and digital ecosystem, likely to enhance marketing and drive product adoption

Artificial Intelligence▲

Off-coverage companies 1

MERGEi
Private▲ PositiveDemandrelevance

Named Agency of Record for Supernus' ADHD treatment QELBREE and digital ecosystem, expanding scope of work